Xtalks Life Science Podcast cover art

All Episodes

Xtalks Life Science Podcast — 258 episodes

#
Title
1

Why Endometriosis Needs New Treatment Approaches with EndoCyclic Therapeutics’ Dr. Tanya Petrossian

2

Precision Oncology in Lung Cancer with Boehringer Ingelheim’s Itziar Canamasas and Volker Teichgräber

3

Sustainability in Asthma and COPD Drug Development with Chiesi’s Diego Ardigò

4

What’s Next in Cardiometabolic Disease Drug Development: Obesity, MASH and Beyond with MetaVia’s Hyung Heon Kim

5

How Real-World Evidence Is Shaping Inclusive Clinical Trials with Takeda CMO Dr. Awny Farajallah

6

Stem Cell Therapies for Degenerative Disc Disease and More with BioRestorative’s Lance Alstodt

7

New Blood Test for Early Alzheimer’s Detection with FNIH’s Dr. Alessio Travaglia

8

Targeting Ischemic Disease with DiaMedica CEO Rick Pauls

9

Why Copyright Matters in Life Sciences in the Age of AI: Featuring Neal Dunkinson of Copyright Clearance Center

10

Neuromodulation and Nerve Ablation for Chronic Pain with NeuroOne CEO Dave Rosa

11

Off the Shelf Cell Therapies for Bone Marrow Transplantation with Ossium Health’s Kevin Caldwell

12

Scalable Biologics Production Trends: Featuring Omar Wahab of Lonza

13

Novel Therapeutic and Trial Approaches for Lysosomal Storage Disorders with Polaryx’s Alex Yang

14

Psilocybin Treatments for Treatment-Resistant Depression with Compass Pathways’ Dr. Steve Levine

15

First Surrogate Endpoint in Osteoporosis Drug Trials with FNIH’s Dr. Tania Kamphaus

16

From Insights to Impact: Rare Disease Therapies with UCB’s Dr. Kim Moran

17

Rare Disease Day Insight: Epilepsy Care Gaps in Pregnancy with UCB’s Andrea Wilkinson

18

Anti-Aging Gene Therapy in Alzheimer’s and ALS with Klotho Neurosciences’ Dr. Joseph Sinkule

19

Translating Nerve Growth Factor Biology into Ocular Disease Therapies with Dompé’s Dr. Ahmed Enayetallah

20

Innovative Approaches to Regenerative Therapies in Wound Care with BioStem CEO Jason Matuszewski

21

Fostering Collaboration to Accelerate Drug Discovery with the Chicago Biomedical Consortium’s (CBC) Dr. Michelle Hoffmann

22

How Public-Private Partnerships Are Advancing Biomedical Research with FNIH’s Dr. Stacey Adam

23

Targeting Inflammation in Eye Diseases with Iolyx Therapeutics’ CEO Elizabeth Jeffords

24

Pioneering Biosensors for Continuous Medical Monitoring with Profusa CEO Dr. Ben Hwang

25

The Biology of Aging: Innovations in Cellular Rejuvenation with Life Biosciences’ Dr. Sharon Rosenzweig-Lipson

26

The Evolving Landscape of Respiratory and Immunology Drug Development with AstraZeneca’s Dr. Andrew Menzies-Gow

27

Restoring Lost Synapses in ALS, Fragile X and More with Spinogenix’s Dr. Peter Vanderklish

28

Targeting Protein Misfolding and Innovations in Hepatobiliary Disease with Rectify Pharma’s Dr. Pol Boudes

29

Advancing Rare Disease Treatment and Care with Takeda’s Dr. Mike Denne

30

Advancing Innovations for Diabetes and Cardiovascular Disease with Lexicon Pharmaceuticals’ CEO Mike Exton

31

At the Heart of Gene Therapy: Lexeo’s R. Nolan Townsend on Genetic Medicines for Cardiovascular Diseases and More

32

Teaching the Pancreas to Heal Itself: Dr. Juan Domínguez-Bendala on Regenerative Diabetes Research

33

From Lab to Launch: Spinning out Biotech Innovation with RBL’s Dr. Paul Wotton

34

Exploring the Future of Cannabinoid & Psychedelic Therapies with Joel Latham of Incannex Healthcare

35

Driving Innovation in Oncology: Insights from Jeff Glazier of General Oncology

36

The Next Generation of Cell Therapy with Cartherics’ COO Dr. Ian Nisbet

37

Why MASH Matters: The Next Steps in Liver Disease Innovation with 89bio’s Rohan Palekar

38

Bridging Aesthetics and Therapeutics in Dermatology with Galderma’s Dr. Bill Andriopoulos

39

The Neuroscience of Weight Regulation with Courage Therapeutics’ Dr. Roger Cone

40

Exploring Immunomodulation Without Immunosuppression with Artax Biopharma’s Dr. Rob Armstrong

41

Advancing Neurotherapeutics for Fragile X and Beyond with Spinogenix CMO Dr. Craig Erickson

42

Driving Neuro Innovation with Neurizon Therapeutics CEO Dr. Michael Thurn

43

Restoring Synapses to Fight ALS, Alzheimer’s and More with Spinogenix CEO Dr. Stella Sarraf

44

Championing the Patient Voice with Ardelyx’s Chief Patient Officer Dr. Laura Williams

45

Inside AI-Powered Drug Discovery with Gain Therapeutics’ CEO Gene Mack

46

Targeting Mast Cells: A New Frontier in Allergy & Inflammation with Jasper Therapeutics’ CMO Dr. Edwin Tucker

47

Reprogramming Cancer: A New Era of AI-Powered Immunotherapy with CancerVax’s Adam Grant

48

Understanding Desmoid Tumors: Insights from Dr. Alessandra Maleddu, Sarcoma Specialist at University of Colorado

49

Advancing Dendritic Cell Immunotherapy for Glioblastoma: Insights from Diakonos Oncology’s Jay Hartenbach

50

Pioneering A New Era of T-Cell Immunotherapy with CERo Therapeutics’ CEO Chris Ehrlich

51

Radiopharmaceuticals and the Future of Nuclear Medicine with RadioMedix CEO Dr. Ebrahim Delpassand

52

Building the Future of Brain Health: Neuroscience Drug Development with Novartis’ Dr. Norman Putzki

53

Rare Disease Innovation in an Evolving Industry with Amgen’s Dr. Sumita Bhatta

54

Advancing Novel Immunotherapy Approaches for Osteosarcoma and Beyond with Paul Romness, CEO of OS Therapies

55

Targeting the Cell’s Powerhouse: Dr. Shaharyar Khan on Rivus Pharma’s Mitochondrial Approach to Cardiometabolic Diseases

56

Inside the Latest in Targeted Radiotherapeutics with Plus Therapeutics CEO Dr. Marc Hedrick

57

From Lab to Launch: Commercializing Gene Therapies for Rare Diseases with Rocket Pharma’s Carlos Martin

58

Combating Autoimmunity: Vera Therapeutics CEO Dr. Marshall Fordyce Discusses Advancing IgAN Treatments

59

Targeting Pressing Unmet Needs in Kidney Diseases with Unicycive Therapeutics CEO Dr. Shalabh Gupta

60

Innovating Treg Therapies for ALS and Alzheimer’s with Coya Therapeutics CEO Dr. Arun Swaminathan

61

The Path to Healthy Aging: Pioneering Therapies for Age-Related Diseases with Rejuvenate Biomed's Ann Beliën

62

Driving Innovations in Rare Diseases with Takeda’s Anthea Cherednichenko

63

Advancing Alzheimer’s Diagnostics: Insights from ALZpath VP of R&D Dr. Lee Honigberg on the Future of Blood-Based Biomarker Assays

64

Advancing PTSD Treatment with Digital Brain Biomarkers ft. Oded Kraft, Co-Founder, CEO and President of GrayMatters Health

65

Innovating Immune-Modulating Therapies in Autoimmune Disorders ft. Dr. Mario Marcondes, VP Head of Clinical Development, Nektar Therapeutics

66

Advancing Digital Approaches in Alzheimer’s Research and Care ft. Sarah Averill Lott, Research Lead, Digital Medicine Society (DiMe) & Diane Stephenson, Executive Director, Critical Path for Parkinson

67

Transformative Neuropsychiatric Therapies ft. Dr. Amit Etkin, Founder, President and CEO of Alto Neuroscience

68

Pioneering Cancer Treatment with Alpha Radiation Technology ft. Alpha Tau Medical CMO Dr. Robert Den

69

Innovations in Immunomodulators for Diseases of the Immune System ft. Dr. Judy Chou, CEO, AltruBio

70

Innovating Cell-Based Solutions for Type 1 Diabetes ft. Jonathan Rigby, CEO, Sernova

71

Immune-Based Intratumoral Cancer Therapies ft. Intensity Therapeutics founder and CEO Lewis Bender

72

Targeting Cancer Drug Resistance with Kairos Pharma’s CEO Dr. John Yu

73

Innovating Immunotherapeutics with Oncolytic Virus Therapy ft. Oncolytics Biotech’s CMO Dr. Thomas Heineman

74

Laser Vision: Pioneering Laser Innovations for Presbyopia ft. Ace Vision’s Dr. AnneMarie Hipsley

75

Bringing the Tech Revolution to Medicine with Digital Therapeutics ft. Click Therapeutics’ CMO Dr. Shaheen Lakhan

76

Inside the Latest Advances in Hearing Tech ft. Envoy Medical CEO Brent Lucas

77

Advances in Heart Failure Treatment ft. Dr. Robert Perkins, VP, US Medical Affairs/Renal, Bayer

78

Transforming Clinical Research: A Conversation with Morgan Hanger, Executive Director of CTTI

79

Innovative Approaches to Antiviral Drug Development

80

A Unique Approach to in vivo CAR T Therapy and New Advancements in the Field

81

The Promise of Epigenetic Therapeutics in Alcohol-Associated Hepatitis ft. DURECT President and CEO Dr. James Brown

82

Pioneering mRNA Therapies for Lung Diseases

83

Silencing Disease: Shifting Treatment Paradigms with RNAi Therapeutics ft. Alnylam’s VP Research Dr. Kirk Brown

84

The Science of Sleep: Unmet Needs and Treatments for Narcolepsy ft. Avadel Pharma’s Dr. Jennifer Gudeman

85

Non-Hormonal Innovations in Obesity and Diabetes Treatment with Aphaia Pharma’s Dr. Steffen-Sebastian Bolz

86

FNIH Study Shows Promise of Blood Tests for Alzheimer’s Disease, featuring Dementia Expert Dr. Schindler and FNIH Neuroscience Director Dr. Travaglia

87

Beyond the Beat: Dr. Matthew Martinez Discusses HCM Care in Athletes and New Camzyos Guidelines

88

Bridging Science and Advocacy with Lawreen Asuncion, Life Science Professional and Rare Disease Patient Advocate

89

Bringing Integrated Nutritional and Pharmaceutical Approaches to the Table for GI Health with Nestlé Health Science’s Moreno Perugini

90

Innovating Approaches to Target Diseases of Aging with Jerry McLaughlin, CEO of Life Biosciences

91

Golden Innovations: Nanocrystal Therapies for ALS and MS with Clene Nanomedicines’ Dr. Karen Ho

92

From Symptoms to Solutions: Transforming Menopause Treatment with Marci English of Astellas Pharma

93

New Frontiers in MASH and Chronic Liver Diseases with Aligos CEO Dr. Lawrence Blatt

94

FNIH’s Dr. Travaglia and ALS Patient Advocate Dr. Sethi Discuss New ALS Program

95

The Road Ahead for Former ALS Hopeful Relyvrio ft. Amylyx's Joshua Cohen and Justin Klee

96

Insights into Precision Dosing with Dr. Howard McLeod and Dr. Sharmeen Roy

97

Targeting AML with a New Generation of T-Cell Therapies, ft. Brian Atwood, Chairman and CEO of CERo Therapeutics

98

Exploring Next-Gen Antivirals ft. Sam Lee, PhD, Co-CEO & President, Cocrystal Pharma

99

Gene Editing Innovations with Programmable Gene Insertion (PGI) Technology ft. Dr. John Finn, Tome Biosciences

100

New Frontiers in Epilepsy and Seizure Treatments ft. Dr. Jeremy Levin and Meg Alexander, Ovid Therapeutics

101

The State of Infectious Diseases and New Trivalent Flu Vaccine ft. Infectious Disease Experts Dr. William Schaffner and Dr. Kelly Moore

102

Psychedelic-Based Therapeutics for Generalized Anxiety Disorder (GAD) – Interview with Robert Barrow, CEO, MindMed

103

Developing Conditionally Active Antibodies: Interview with John K. Celebi, President & CEO, Sensei Bio.

104

Treg Cell Therapy for Neurodegenerative Diseases – Interview with Dr. Howard Berman, CEO, Coya Therapeutics

105

Improving Cancer Screening Among Métis Communities: Interview with Margaret Froh, President, Métis Nation of Ontario

106

Cell Therapies for Chronic Kidney Disease: Featuring Bruce Culleton, CEO, ProKidney

107

Tackling Diabetic Kidney Disease: Featuring Robert Perkins, VP, US Medical Affairs (Renal), Bayer

108

People in Life Sciences Series: Day-in-the-Life of a Pharmacovigilance Professional – Interview with Ashish Jain, Senior Director of Clinical Safety a...

109

Building Cancer Awareness and Empowering Métis Youth: Featuring Jordyn Playne, President, Métis Nation of Ontario Youth Council

110

Transforming Eye Care: Innovating New Glaucoma and Dry Eye Disease Treatments

111

Rare Disease Day 2024: Highlighting Patient Stories and Advancements in Rare Disease Research

112

Biologics Development in Immunology and Inflammation — Featuring Amir Reichman, CEO of Scinai Immunotherapeutics

113

Novel Approaches in Cancer Immunotherapy — Featuring OncoC4 founder, CEO and CSO Dr. Yang Liu and CFO Abid Ansari

114

New Targeted Treatments for Breast Cancer — Conversation with Dr. Carlos Doti, VP, US Medical Affairs Oncology, AstraZeneca

115

Exploring the Endocannabinoid System for Drug Development, Featuring Punit Dhillon, Chairman & CEO of Skye Bioscience

116

Life Science Trends for 2024

117

Revolutionizing Orthopedic Joint Replacement — Interview with Ben Sexson, Co-Founder, CEO, Monogram Orthopedics

118

Cognitive and Neuropsychiatric Disorders Drug Development, Featuring Dr. Adam Kaplin, Cofounder, President, CSO, MIRA Pharmaceuticals

119

Pneumococcal Vaccination for Adults: Conversation with Vaccine Scientists Dr. Heather Platt and Dr. Ulrike Buchwald from Merck

120

A Focus on Men’s Health — Conversation with Fady Boctor, Petros Pharma President and CCO

121

“Off-the-Shelf” Cellular Therapy: Interview with Longeveron CEO Wa’el Hashad

122

Attorney Tope Leyimu Discusses Proposed FDA ban on Hair Relaxer Products Containing Harmful Chemicals

123

Dr. Lahar Mehta Speaks About New Trial to Evaluate ALS Drug for Progressive Supranuclear Palsy

124

FDA Considers Self Administered Nasal Flu Vaccine + Wayne Gretzky Features in GSK RSV Vaccine Ad

125

Innovations and Clinical Trial Diversity in Medical Aesthetics: Insights from Dr. Stephanie Manson Brown, VP & Head of Clinical Development at Allerga...

126

Lead Investigator Dr. Genevieve Neal-Perry Discusses New Trial Data for Astellas’ Menopause Drug Fezolinetant (Veozah)

127

Johnson & Johnson Faces Lawsuit Over Patient Data Breach + Sleepiz’s Sleep Monitoring Device Gets FDA Clearance

128

Advancing CAR T Cell Therapies in Immuno-Oncology – Featuring Dr. Paul Rennert, CEO, CSO, Aleta Biotherapeutics

129

New HPV Vaccine Data Shows Long-Term Impact – Featuring Dr. Elmar Joura from the Medical University of Vienna

130

Interview with Dr. Kristin Yarema, President of Cell Therapy at Poseida Therapeutics

131

Advancements in Blood-Based Biomarker Tests for NASH — Interview with Dr. Tania Kamphaus and Tony Villiotti

132

Insights into New Alzheimer’s Treatments: Treating Agitation and First THC-Based Therapeutic in Trials — Interview with IGC’s Ram Mukunda and Claudia ...

133

Discussing Next Generation Chemotherapy Drugs with Processa Pharma’s Dr. David Young

134

More US States Take on Eli Lilly in Court Over Proposed Insulin Pricing Settlement + Regeneron’s High Dose Eylea Wins FDA Approval

135

Interview with BriaCell’s CEO Dr. William Williams

136

First Oral Tablet for Postpartum Depression + Court Rejects JJ’s Latest Bankruptcy Attempt

137

FDA Clearances for World’s Smallest Insulin Pump + New Cardiac Biomarker Test

138

In Conversation with Principal Investigator and SME Dr. Lawrence Eichenfield About the FDA Approval of a Drug-Device Combo for Common Skin Infection

139

Point-of-Care Testing for Infectious Diseases: Senzo CEO Jeremy Stackawitz Speaks About Company’s New Lateral Flow Technology

140

Biosimilars and the Problem with PBMs: Interview with Juliana M. Reed, Executive Director of the Biosimilars Forum

141

Opioid Use Disorder and Brixadi Approval: Interview with Dr. Joshua Cohen, Chief Medical Officer at Braeburn

142

Developing More Affordable Cellular Immunotherapies: Interview with CytoMed Therapeutics

143

Xtalks Speaks with Astellas Pharma’s VP & Head of BioPharma Development Marci English About Menopause Drug Approval

144

Wireless Charging for Medical Devices: Interview with Resonant Link’s CEO and Co-Founder Dr. Grayson Zulauf

145

In conversation with FNIH’s Dr. Courtney Silverthorn, Director of the AMP Bespoke Gene Therapy Consortium, About New Rare Disease Trial Portfolio

146

AI and ChatGPT for Medical Record Management: Interview with Carm Huntress, CEO and Founder of Credo Health

147

First Topical Gene Therapy + Bausch + Lomb’s First Prescription Med for Dry Eye

148

Veozah the New Drug for Menopausal Hot Flashes + SkinVive the New Dermal Filler

149

Interview with Dr. Gillian Woollett, VP, Head of Regulatory Strategy and Policy at Samsung Bioepis

150

World’s First RSV Vaccine + First Novel Treatment for ALS

151

Axonics’ Non-Drug Incontinence Therapy + How AI Can Be Used to Study the Side Effects of Drugs

152

Interview with Cody Simmons, CEO of DermaSensor, Maker of a Handheld Skin Cancer Evaluation Tool

153

EPA Proposes Stricter Ethylene Oxide Limits + Johnson and Johnson Offers $8.9 Billion Settlement

154

Interview with Wei-Li Shao, President Virtual Care Company Omada Health

155

Pharma By The Numbers: Celebrating 20 Years of Xtalks with an Analysis of the Industry

156

Interview with Definitive Healthcare’s VP, Head of Healthcare Consulting, Manu Garg, about Healthcare Commercial Intelligence

157

Interview with Tidepool’s CEO and Co-Founder Howard Look About an Automated Insulin Dosing App for Type 1 Diabetes

158

Interview with Neuromod COO Diarmuid Flavin About the FDA Approval of Tinnitus Treatment Lenire

159

FDA approval of First Geographic Atrophy Treatment and Authorization of First At-Home Combo COVID-19 and Flu Test

160

Interview with Cala Health’s CCO Doug Biehn about Neuromodulation Therapy Cala Trio for Hand Tremors

161

Sunrise’s At-Home Sleep Apnea Test Gets FDA Clearance + BMS-Pfizer Team up with Kareem Abdul Jabbar for AFib Awareness

162

Interview with Polarean Imaging CTO Dr. Bastiaan Driehuys on the FDA Approval of Lung Imaging Drug Device Combo Xenoview

163

Amgen Launches Humira Biosimilar Amjevita + Potential New Blood Test for Early Detection of Alzheimer’s

164

Amazon’s New $5 Prescription Drug Program + Top 10 Pharma TV Ad Spenders in 2022

165

Interview with Thea Pharma’s Susan Benton about Eye Care and the FDA Approval of Iyuzeh

166

XBB.1.5 Omicron Subvariant + FDA Approves AstraZeneca’s New Asthma Inhaler

167

Interview with Breast Surgical Oncologist Dr. Monique Gary on Cancer Health Disparities

168

Life Science Trends for 2023

169

Interview with the leaders at Amylyx, Maker of New FDA Approved ALS Drug Relyvrio

170

FDA Approves First Fecal Matter Therapy + PureTech Reveals New CBD Oral Capsule

171

First Gene Therapy Approved for Hemophilia B + World AMR Awareness Week

172

FDA Approves First Drug to Delay T1D + Positive Data for Pfizer’s Maternal RSV Vaccine

173

Novo Nordisk’s Ozempic (Semaglutide) Shortage and Fake Eli Lilly Twitter Account Announces Free Insulin

174

Interview with Eye Health Biotech Santen Pharmaceuticals’ CMO Peter Sallstig

175

FDA Approves Immunotherapies for Multiple Myeloma and Liver Cancer

176

Interview with Cystic Fibrosis and Rare Disease Patient Leader Gunnar Esiason

177

Elon Musk Reveals he Used Novo’s Wegovy for Weight Loss + FDA Approval of Nevro’s AI Spinal Cord Stimulation System

178

Bimodal Neuromodulation for Tinnitus: Interview with Caroline Hamilton, Clinical Director of Neuromod Devices – Xtalks Life Science Podcast Ep. 81

179

The Neurolenses Solution for Digital Vision Syndrome: Interview with Pierre Bertrand, CEO of Neurolens

180

FDA Approves World’s Most Expensive Gene Therapy for Rare Disease + CDC Concerned About New COVID-19 Variant

181

How Air Pollution Triggers Lung Cancer + Scientists Develop Parkinson’s Test Based on Woman’s Ability to Smell It

182

FDA Approval of Sanofi’s Enzyme Replacement Drug for ASMD + Disney Actress Partners with Medtronic for Diabetes Tech Campaign

183

Fitbit Introduces New Smartwatch with AFib Detection + FDA Approves Imbruvica for Pediatric Patients with cGVHD

184

FDA Approval of First Rapid-Acting Oral Depression Drug + Approval of $2.8 Million Gene Therapy for Rare Blood Disorder

185

Interview with Asaf Zviran, CEO of Cancer Genomics Company C2i Genomics

186

UK Approves First Omicron-Targeting COVID Vaccine + National Immunization Awareness Month

187

New COVID-19 Testing Technology + FDA Approves First Drug for HER2-Low Breast Cancer

188

FDA Approvals for Liquid Epilepsy Drug and a Vitiligo Medication

189

Towards a ’Functional Cure’ for Diabetes with Dr. Philip Toleikis, CEO, Sernova Corp

190

Expanded Approval for Gout Drug + Novavax COVID-19 Vaccine Gets FDA Authorization

191

FDA Issues Safety Warning for Blood Cancer Drug + Long COVID Risk Assessment Tool

192

BD Develops New Monkeypox Test + FDA Authorizes COVID-19 Vaccines for Infants

193

Eli Lilly’s Olumiant FDA Approved for Alopecia + Alnylam’s RNAi Drug Amvuttra Approved for Rare Protein Disorder

194

More Positive Data for Tirzepatide Weight Loss Injection + Sandoz’s Global Biosimilars Awareness Campaign

195

Interview with Georgia Tech’s Dr. Woon-Hong Yeo About a New Smart Stent Platform for Wireless Vascular Monitoring

196

Interview with Dr. Samantha Dale Strasser, CSO and Co-Founder of Transomics Drug Discovery Start-Up ”Pepper Bio”

197

FDA Approves New Type 2 Diabetes Injection Mounjaro + US Reports First Case of Monkeypox

198

Messaging Program Improves Lifestyle Among Heart Attack Survivors + FDA Places Stricter Restrictions on Janssen COVID-19 Vaccine

199

FDA Approves Bristol Myers’ Cardiac Drug for HCM + New Ovarian Cancer Blood Test

200

First FDA-Approved Treatment for Chronic Yeast Infection + Eli Lilly Obesity Drug Shows Promise in Trials

201

World Immunization Week 2022 + New COVID-19 Breath Test Gets FDA Authorization

202

BioNTech Partners for mRNA Vaccine Delivery Tech + Pfizer Acquires ReViral for RSV Therapeutics

203

Statins May Lower Parkinsonism Risk + New Genetic Test to Prevent Deafness in Babies

204

Clinical Trial Diversity Insights from NIH Experts + WHO and Polluted Air on World Health Day 2022

205

Pfizer Recalls Blood Pressure Medication + Jazz Pharma Manufacturing Cannabis-Based Medications

206

Exact Sciences and Katie Couric’s Colon Cancer Awareness TV Ad + Alnylam Sues Pfizer and Moderna Over Patent Infringements

207

Johnson & Johnson Funding Human Asbestos Studies + Swift Medical’s Imaging Device for Remote Digital Wound Care

208

Celebrating Women’s Leadership in Life Sciences on International Women’s Day + Johnson & Johnson’s Cell Therapy for Multiple Myeloma Gets FDA Approval

209

Marking Rare Disease Day 2022 by Sharing Colours + Why Black People Remain Underrepresented in Clinical Trials

210

BioNTech Unveils Modular mRNA Factories for Africa + FDA Authorizes Eli Lilly Monoclonal Antibody Effective Against Omicron

211

UK’s NHS Backs World’s Costliest Drug for Treatment of MLD + Report Finds Increase in Pharma Cybersecurity Threats

212

Inbody’s At-Home Real Time Blood Pressure Monitoring + Eli Lilly Announces Investments into New Manufacturing Facilities

213

FDA Approval for First TCR Therapy for Uveal Melanoma + Pfizer and Moderna Begin Trials for Omicron Booster

214

Gilead Sues Over Counterfeit HIV Drugs + Menarini’s New Rapid COVID-19 PCR Test

215

Study Shows Exercise Can Maintain Cognitive Health in Elderly + Abbott’s New Cardiac Mapping System

216

New Cancer Blood Test + Bayer Commits to All Green Packaging by 2030

217

FDA and CDC Update Guidelines Amid Omicron + Life Science Trends for 2022

218

Biohaven Intranasal Migraine Drug Gets FDA Approval + Moderna’s mRNA Influenza Vaccine

219

Moderna and Pfizer Premature Statements on Omicron + FDA Approves New Hepatitis B Vaccine

220

WHO Declares Omicron Variant of Concern + Seizure Drug Recalled Over Faulty Seal

221

Virtual Reality Treatment for Chronic Pain + Canadian CDMO Biovectra to Build mRNA Manufacturing Plant

222

Xtalks Voices: Magnus Medical CEO Dr. Brett Wingeier Talks About Neurostimulation for Depression

223

Pfizer’s COVID-19 Antiviral Pill + FDA Approves AbbVie’s Eyedrop for Presbyopia

224

FDA Authorizes Pfizer COVID-19 Vaccine for Children 5 to 11 + Genentech’s Drug Delivery System for Macular Degeneration

225

FDA Approves Interchangeable Humira Biosimilar + Gene Silencing Treatment for Porphyria Gets Nod From England’s NICE

226

Moderna Unwilling to Share COVID-19 Recipe + Singer Mary J Blige Partners with Hologic for Breast Cancer Awareness

227

Researchers Develop Arthritis Vaccine + Medtronic Expands Recall on Insulin Pumps

228

CDC Says Flu and COVID-19 Shots Can Be Co-Administered + Merck’s Oral Antiviral for COVID-19 Shows Stellar Results

229

New FDA ”Bad Ad” Quiz + Pfizer COVID-19 Vaccine Data for Young Children

230

FDA on COVID-19 Vaccine Boosters + Advocacy Group Pushes for Speedy FDA Approval of ALS Drug

231

Eli Lilly to Develop RNA Editing Therapies + Study Shows Benefits of Daily Steps

232

World’s First Smart Knee + Alzheimer’s Blood Test

233

Why Antimicrobial Resistance is a Silent Pandemic

234

How the Approval of Aducanumab Will Change Alzheimer’s Trials

235

FDA Authorizes COVID-19 Vaccine Boosters for Immunocompromised Individuals

236

AAIC 2021 – COVID-19 Impacts on Cognitive Health + Pancreatic Cancer Blood Test

237

AAIC 2021 - Diversity in Clinical Trials + Johnson & Johnson Sued by Black Women’s Group

238

AAIC 2021 – Aduhelm Recommendations + Pfizer’s Expanded Chantix Recall

239

WHO Comments on COVID-19 Vaccine Mixing + World’s First Glucose Saliva Test

240

Nestlé to Market Oral Microbiome Drug for C. Difficile + WHO Recommends IL-6 Blockers as Life-Saving COVID-19 Treatment

241

First FDA-Approved Video Game for ADHD + Why Not to Worry About Menstrual Changes After COVID-19 Vaccination

242

NeuraLace’s Peripheral Nerve Stimulation System for Chronic Pain + AstraZeneca Fights COVID Vaccine Delivery Lawsuit

243

Measuring Body Fat Percentage with Amazon’s Halo app + Regeneron’s Antibody Treatment Cuts Risk of COVID-19 Deaths

244

World’s First Digital Fabric + Amazon’s Direct-to-Consumer COVID-19 Test

245

Fruit and Type 2 Diabetes Risk + Moderna’s Manufacturing Partnerships

246

Google’s AI Dermatology App + WHO’s Investigations into the Coronavirus Lab Leak Theory

247

Clinical Trials Day 2021 + AbbVie’s Humira Monopoly

248

Pharma TV Ad Spending Trends + AI Algorithm for Heart Disease

249

Epigenetic Editing with CRISPR + ADHD in Preschoolers

250

At-Home Sleep Apnea Test + Neurological Rehabilitation Device for Stroke Patients

251

Malaria Vaccine + Sugar’s Effect on Brain Development in Children

252

J&J COVID-19 Vaccine and Thrombosis + Medtronic’s Harmony Transcatheter Pulmonary Valve Approval

253

Parkinson’s Disease: Link With Melanoma + Drug Development

254

Social Media’s Disinformation Dozen + Pfizer’s Latest COVID-19 Vaccine Trial Results

255

Caffeine Consumption in Pregnancy + Portable Neuromodulation Stimulator for MS

256

COVID-19 Pandemic Anniversary + Cancer Biotech Acquisitions

257

Why You Can’t Compare COVID-19 Vaccine Efficacies

258

Mask-Associated Dry Eye + Droplet Micron Insulin Needle